3 Likes
Seems like a good opportunity to do some clinical studies on longevity drugs.
Get a group of a few hundred “generally healthy” 90 year olds, randomly assign them to control groups or treatment groups (rapamycin, SGLT2 inhibitors, etc.) and track their health over the next decade…
1 Like